460 related articles for article (PubMed ID: 32228271)
21. Racial differences in body composition and survival among older adults with gastrointestinal malignancies.
Aleixo GFP; Hess DL; Fowler ME; Giri S; Williams GR
J Geriatr Oncol; 2024 May; 15(4):101747. PubMed ID: 38513310
[TBL] [Abstract][Full Text] [Related]
22. Effect of muscle depletion on survival in peripheral arterial occlusive disease: Quality over quantity.
Vedder IR; Levolger S; Dierckx RAJO; Zeebregts CJ; de Vries JPM; Viddeleer AR; Bokkers RPH
J Vasc Surg; 2020 Dec; 72(6):2006-2016.e1. PubMed ID: 32330596
[TBL] [Abstract][Full Text] [Related]
23. Association between Abdominal CT Measurements of Body Composition before Deceased Donor Liver Transplant with Posttransplant Outcomes.
Shafaat O; Liu Y; Jackson KR; Motter JD; Boyarsky BJ; Latif MA; Yuan F; Khalil A; King EA; Zaheer A; Summers RM; Segev DL; McAdams-DeMarco M; Weiss CR
Radiology; 2023 Mar; 306(3):e212403. PubMed ID: 36283115
[TBL] [Abstract][Full Text] [Related]
24. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
[TBL] [Abstract][Full Text] [Related]
25. Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population.
Weinberg MS; Shachar SS; Muss HB; Deal AM; Popuri K; Yu H; Nyrop KA; Alston SM; Williams GR
Breast J; 2018 May; 24(3):278-284. PubMed ID: 29139618
[TBL] [Abstract][Full Text] [Related]
26. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
[TBL] [Abstract][Full Text] [Related]
27. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
28. Comparing Western and Eastern criteria for sarcopenia and their association with survival in patients with pancreatic cancer.
Wu CH; Chang MC; Lyadov VK; Liang PC; Chen CM; Shih TT; Chang YT
Clin Nutr; 2019 Apr; 38(2):862-869. PubMed ID: 29503056
[TBL] [Abstract][Full Text] [Related]
29. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery.
Rutten IJ; Ubachs J; Kruitwagen RF; van Dijk DP; Beets-Tan RG; Massuger LF; Olde Damink SW; Van Gorp T
Eur J Surg Oncol; 2017 Apr; 43(4):717-724. PubMed ID: 28159443
[TBL] [Abstract][Full Text] [Related]
30. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
[TBL] [Abstract][Full Text] [Related]
31. Rapid decline in visceral adipose tissue over 1 month is associated with poor prognosis in patients with unresectable pancreatic cancer.
Nakano O; Kawai H; Kobayashi T; Kohisa J; Ikarashi S; Hayashi K; Yokoyama J; Terai S
Cancer Med; 2021 Jul; 10(13):4291-4301. PubMed ID: 33993635
[TBL] [Abstract][Full Text] [Related]
32. Nutritional status and skeletal muscle status in patients with head and neck cancer: Impact on outcomes.
Findlay M; White K; Brown C; Bauer JD
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2187-2198. PubMed ID: 34676673
[TBL] [Abstract][Full Text] [Related]
33. Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
Hopkins JJ; Skubleny D; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
Ann Surg Oncol; 2018 May; 25(5):1381-1394. PubMed ID: 29488190
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of Artificial Intelligence-Driven, Computed Tomography-Based, Volumetric Assessment of the Volume and Density of Muscle in Patients With Colon Cancer.
Kim M; Lee SM; Son IT; Park T; Oh BY
Korean J Radiol; 2023 Sep; 24(9):849-859. PubMed ID: 37634640
[TBL] [Abstract][Full Text] [Related]
35. Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality.
Cespedes Feliciano EM; Avrutin E; Caan BJ; Boroian A; Mourtzakis M
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):898-908. PubMed ID: 30066490
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients.
Cespedes Feliciano EM; Popuri K; Cobzas D; Baracos VE; Beg MF; Khan AD; Ma C; Chow V; Prado CM; Xiao J; Liu V; Chen WY; Meyerhardt J; Albers KB; Caan BJ
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1258-1269. PubMed ID: 32314543
[TBL] [Abstract][Full Text] [Related]
37. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
[No Abstract] [Full Text] [Related]
38. Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer.
Lee J; Lin JB; Wu MH; Jan YT; Chang CL; Huang CY; Sun FJ; Chen YJ
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):814-826. PubMed ID: 31094101
[TBL] [Abstract][Full Text] [Related]
39. Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.
Stretch C; Aubin JM; Mickiewicz B; Leugner D; Al-Manasra T; Tobola E; Salazar S; Sutherland FR; Ball CG; Dixon E; Vogel HJ; Damaraju S; Baracos VE; Bathe OF
PLoS One; 2018; 13(5):e0196235. PubMed ID: 29723245
[TBL] [Abstract][Full Text] [Related]
40. Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Kurk SA; Peeters PHM; Dorresteijn B; de Jong PA; Jourdan M; Creemers GM; Erdkamp FLG; de Jongh FE; Kint PAM; Poppema BJ; Radema SA; Simkens LHJ; Tanis BC; Tjin-A-Ton MLR; Van Der Velden A; Punt CJA; Koopman M; May AM
Cancer Med; 2020 Feb; 9(3):1033-1043. PubMed ID: 31850687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
